Chondroitin sulfate is a natural chemical that is primarily found around cartilages in different joints of the body. Conventional techniques of manufacturing chondroitin sulfate involve procurement from animal sources, including cow, bovine, or shark cartilage. Chondroitin sulfate continues to garner considerable popularity around the world due to health benefits and additional research activities. Chondroitin sulfate is mainly used in conjunction with various other ingredients such as glucosamine sulfate, manganese ascorbate, N-acetyl glucosamine, and glucosamine hydrochloride. At present, chondroitin sulfate is increasingly being used to treat osteoarthritis, heart diseases, joint pain, and HIV/AIDS, and other conditions including anemia.
Chondroitin sulfate is administered in different forms such as oral techniques and eye drops. At present, various types of chondroitin sulfate available include powder and pellets. The growing demand for chondroitin sulfate from global biotechnology and pharmaceutical companies is expected to remain one of the key factors that will contribute to the overall growth of the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market during the forecast period. Chondroitin sulfate is increasingly being used in the production of skin creams and ointments that are used to treat osteoarthritis. Due to additional research, applications of chondroitin sulfate continue to widen at an impressive pace– another factor that is expected to immensely contribute to the growth of the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market.
At the back of these factors, the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is expected to attain a market value of US$ 4.7 Bn by the end of 2030.
To know the scope of our report Get a Sample on API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market
Over the past couple of decades, chondroitin sulfate and glucosamine have gained immense popularity around the world for the treatment of osteoarthritis, particularly in developed regions, including Europe and North America. While the demand for chondroitin sulfate for osteoarthritis from Europe continues to remain higher than that of other regions, North America is gradually emerging as a lucrative market for the players operating in the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market. Although the demand for chondroitin sulfate in combination with other ingredients is on the rise, at present, chondroitin sulfate is largely used to minimize the pain among patients with moderate-to-severe pain at the baseline. Moreover, several clinical research activities have revealed that administering chondroitin sulfate by mouth has the potential to improve pain and function in patients suffering from osteoarthritis. Pharmaceutical-grade products with chondroitin sulfate have garnered immense popularity across the healthcare sector around the world due to which, the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is expected to witness a commendable growth during the assessment period.
Get a glimpse of the in-depth analysis through our Report Brochure
Due to the growing amount of research and development activities pertaining to chondroitin sulfate, an array of commercial and potential applications of chondroitin sulfate have emerged over the past few years. However, at present, due to mounting environmental concerns and the impact of currently deployed animal extractive procedures on the environment, stakeholders involved in the current API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market landscape are expected to focus on other sustainable techniques to gain an advantage. At present, chondroitin sulfate is also being used as a food supplement, biopolymer in materials for regenerative medicine, and more due to which, the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is projected to exhibit a consistent growth during the assessment period. Due to environmental concerns coupled with religious concerns, among consumers in different regions, market players have shifted their focus toward good manufacturing practice (GMP). At present, metabolically engineered microorganisms and customized fermentation processes are largely being tried and tested– another major factor that is expected to augment the growth of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market during the assessment period.
Although the COVID-19 pandemic has caused severe losses to companies and industries from different domains, the healthcare sector is expected to have an impressive growth amid the ongoing COVID-19 situation. The demand for chondroitin sulfate is expected to largely remain unaffected during the ongoing public health crisis, as the production and manufacturing of chondroitin sulfate is expected to continue without any interventions. In addition, the sales of medication with chondroitin sulfate, especially among patients suffering from osteoarthritis is likely to move in the upward trajectory during the pandemic. This can be attributed to uncertainty among patients regarding ongoing situation and concerns pertaining to the restriction on movement and transportation.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market is expected to grow at a healthy CAGR of 6.5% during the forecast period. The market growth can be primarily attributed to growing applications of chondroitin sulfate in the production of different medications used to treat various diseases, particularly osteoarthritis. In addition, as manufacturers continue to find sustainable production techniques to manufacture chondroitin sulfate, the demand is further anticipated to grow in the upcoming years. The widening applications of chondroitin sulfate in the healthcare sector will remain the key factor that will boost the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market during the forecast period.
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market – Segmentation
TMR’s study on the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market includes information divided into four sections: product, type, end user, and region. Changing industry trends and other crucial market dynamics associated with these sections of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market have been discussed in detail.
|
Product |
|
|
Type |
|
|
End User |
|
|
Region |
|
API (chondroitin sulfate, hyaluronic acid and pancreatin) market to reach US$ 4.7 Bn by 2030
API (chondroitin sulfate, hyaluronic acid and pancreatin) market is expected to grow at a healthy CAGR of 6.5% during 2020 - 2030
API (chondroitin sulfate, hyaluronic acid and pancreatin) market is driven by rise in prevalence of chronic diseases
North America accounted for a major share of the global API (chondroitin sulfate, hyaluronic acid and pancreatin) market and the trend is likely to continue during the forecast period
Key players in the global API (chondroitin sulfate, hyaluronic acid and pancreatin) market report include Summit Nutritionals International, Inc., Sioux Pharm, Inc., TSI Group Ltd., Shandong Runxin Biotechnology Co., Ltd., ZPD A/S
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Price Comparison Analysis, 2019
5.1.1. By Product Type
5.2. Key Vendor and Distributor Analysis
5.3. Regulatory Scenario by Region/globally
5.4. Value Chain Analysis
5.5. Recent Developments in Technologies
5.6. COVID-19 Epidemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product, 2018–2030
6.3.1. Chondroitin Sulfate
6.3.2. Hyaluronic Acid
6.3.2.1. Natural
6.3.2.2. Synthetic
6.3.3. Pancreatin
6.4. Market Attractiveness Analysis, by Product
7. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2018–2030
7.3.1. Pellets
7.3.2. Powder
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2030
8.3.1. Pharmaceutical Companies
8.3.2. Biotechnology Companies
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product, 2018–2030
10.2.1. Chondroitin Sulfate
10.2.2. Hyaluronic Acid
10.2.2.1. Natural
10.2.2.2. Synthetic
10.2.3. Pancreatin
10.3. Market Value Forecast, by Type, 2018–2030
10.3.1. Pellets
10.3.2. Powder
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2018–2030
10.4.1. Pharmaceutical Companies
10.4.2. Biotechnology Companies
10.4.3. Others
10.5. Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country
11. Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product, 2018–2030
11.2.1. Chondroitin Sulfate
11.2.2. Hyaluronic Acid
11.2.2.1. Natural
11.2.2.2. Synthetic
11.2.3. Pancreatin
11.3. Market Value Forecast, by Type, 2018–2030
11.3.1. Pellets
11.3.2. Powder
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2018–2030
11.4.1. Pharmaceutical Companies
11.4.2. Biotechnology Companies
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product, 2018–2030
12.2.1. Chondroitin Sulfate
12.2.2. Hyaluronic Acid
12.2.2.1. Natural
12.2.2.2. Synthetic
12.2.3. Pancreatin
12.3. Market Value Forecast, by Type, 2018–2030
12.3.1. Pellets
12.3.2. Powder
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2018–2030
12.4.1. Pharmaceutical Companies
12.4.2. Biotechnology Companies
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product, 2018–2030
13.2.1. Chondroitin Sulfate
13.2.2. Hyaluronic Acid
13.2.2.1. Natural
13.2.2.2. Synthetic
13.2.3. Pancreatin
13.3. Market Value Forecast, by Type, 2018–2030
13.3.1. Pellets
13.3.2. Powder
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2018–2030
13.4.1. Pharmaceutical Companies
13.4.2. Biotechnology Companies
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product, 2018–2030
14.2.1. Chondroitin Sulfate
14.2.2. Hyaluronic Acid
14.2.2.1. Natural
14.2.2.2. Synthetic
14.2.3. Pancreatin
14.3. Market Value Forecast, by Type, 2018–2030
14.3.1. Pellets
14.3.2. Powder
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2018–2030
14.4.1. Pharmaceutical Companies
14.4.2. Biotechnology Companies
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share/Position Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. Summit Nutritionals International, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Sioux Pharm, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. TSI Group Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Shandong Runxin Biotechnology Co., Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. ZPD A/S
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Pacific Rainbow International, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. SEIKAGAKU CORPORATION
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Synutra, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Bioiberica S.A.U.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Newgen Biotech USA Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Nordmark Arrzneimittel GmbH & Co. KG
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. Qingdao WanTuMing Biological Products Co., Ltd.
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
List of Tables
Table 01: Key Vendor and Distributor Analysis
Table 02: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 03: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 04: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 05: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 06: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 07: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 08: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Region, 2018–2030
Table 10: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 11: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 12: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 13: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 14: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 15: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 16: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 19: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 20: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 21: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 22: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 23: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 24: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 25: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 26: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 27: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 28: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 29: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 30: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 31: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 33: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 34: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 35: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 36: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 37: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 38: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 39: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 40: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030
Table 41: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030
Table 42: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030
Table 43: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 44: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, 2018–2030
Figure 03: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share, by Product (2019)
Figure 04: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share, by Type (2019)
Figure 05: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share, by End-user (2019)
Figure 06: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share, by Region (2019)
Figure 07: Chondroitin Sulfate, Global Average Price (US$) per Ton
Figure 08: Hyaluronic Acid, Global Average Price (US$) per Ton by Source
Figure 09: Pancreatin, Global Average Price (US$) per Ton
Figure 10: Regulatory Approval Process - U.S.
Figure 11: Regulatory Approval Process - Europe
Figure 12: Regulatory Approval Process - Japan
Figure 13: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share Analysis, by Product, 2019 and 2030
Figure 14: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chondroitin Sulfate, 2018–2030
Figure 15: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hyaluronic Acid, 2018–2030
Figure 16: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn), by Pancreatin, 2018–2030
Figure 17: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Product, 2020–2030
Figure 18: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share Analysis, by Type, 2019 and 2030
Figure 19: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pellets, 2018-2030
Figure 20: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Powder, 2018-2030
Figure 21: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn), by Others, 2018–2030
Figure 22: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Type, 2020–2030
Figure 23: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share Analysis, by End-user, 2019 and 2030
Figure 24: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical Companies, 2018-2030
Figure 25: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology Companies, 2018-2030
Figure 26: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn), by Others, 2018–2030
Figure 27: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by End-user, 2020–2030
Figure 28: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share Analysis, by Region, 2019 and 2030
Figure 29: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Region
Figure 30: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 31: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Country, 2019 and 2030
Figure 32: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Country, 2020–2030
Figure 33: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Product, 2019 and 2030
Figure 34: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Product, 2020–2030
Figure 35: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Type, 2019 and 2030
Figure 36: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by Type, 2020–2030
Figure 37: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by End-user, 2019 and 2030
Figure 38: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractiveness Analysis, by End-user, 2020–2030
Figure 39: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 40: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030
Figure 41: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Country/Sub-region, 2020–2030
Figure 42: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Product, 2019 and 2030
Figure 43: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Product, 2020–2030
Figure 44: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Type, 2019 and 2030
Figure 45: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Type, 2020–2030
Figure 46: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by End-user, 2019 and 2030
Figure 47: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by End-user, 2020–2030
Figure 48: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 49: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030
Figure 50: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Country/Sub-region, 2020–2030
Figure 51: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Product, 2019 and 2030
Figure 52: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Product, 2020–2030
Figure 53: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Type, 2019 and 2030
Figure 54: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Type, 2020–2030
Figure 55: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by End-user, 2019 and 2030
Figure 56: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by End-user, 2020–2030
Figure 57: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 58: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030
Figure 59: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Country/Sub-region, 2020–2030
Figure 60: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Product, 2019 and 2030
Figure 61: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Product, 2020–2030
Figure 62: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Type, 2019 and 2030
Figure 63: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Type, 2020–2030
Figure 64: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by End-user, 2019 and 2030
Figure 65: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by End-user, 2020–2030
Figure 66: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 67: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Country/Sub-region, 2019 and 2030
Figure 68: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Country/Sub-region, 2020–2030
Figure 69: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Product, 2019 and 2030
Figure 70: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Product, 2020–2030
Figure 71: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by Type, 2019 and 2030
Figure 72: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by Type, 2020–2030
Figure 73: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value Share (%) Analysis, by End-user, 2019 and 2030
Figure 74: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Attractive Analysis, by End-user, 2020–2030
Figure 75: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market
*86 figures and 60 tables includes